Zacks Research Issues Pessimistic Estimate for MRK Earnings
Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Merck & Co., Inc. in a research report issued to clients and investors on Wednesday, February 26th. Zacks Research analyst S. Ganoria now expects that the company will earn $2.19 per share for […]
